ArticleDiabetes2025

Neuroprotective Effect of a Novel Soluble Guanylate Cyclase Activator Runcaciguat in Diabetic and Ischemic Retinopathy.

Elia J Duh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.